» Articles » PMID: 18056394

E- and P-selectin Are Not Required for the Development of Experimental Autoimmune Encephalomyelitis in C57BL/6 and SJL Mice

Overview
Journal J Immunol
Date 2007 Dec 7
PMID 18056394
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

In multiple sclerosis and in its animal model experimental autoimmune encephalomyelitis (EAE), inflammatory cells migrate across the endothelial blood-brain barrier (BBB) and gain access to the CNS. It is well-established that alpha4 integrins are actively involved in leukocyte recruitment across the BBB during EAE. In contrast, the role of endothelial E- and P-selectin in this process has been a controversial issue. In this study, we demonstrate that P-selectin protein can be detected in meningeal blood vessel endothelial cells in healthy SJL and C57BL/6 mice and on rare parenchymal CNS blood vessels in C57BL/6, but not SJL, mice. During EAE, expression of P-selectin but not E-selectin was found up-regulated on inflamed CNS microvessels surrounded by inflammatory infiltrates irrespective of their meningeal or parenchymal localization with a more prominent immunostaining detected in C57BL/6 as compared with SJL mice. P-selectin immunostaining could be localized to CNS endothelial cells and to CD41-positive platelets adhering to the vessel wall. Despite the presence of P-selectin in wild-type mice, E/P-selectin-deficient SJL and C57BL/6 mice developed clinical EAE indistinguishable from wild-type mice. Absence of E- and P-selectin did neither influence the activation of myelin-specific T cells nor the composition of the cellular infiltrates in the CNS during EAE. Finally, endothelial-specific tetracycline-inducible expression of E-selectin at the BBB in transgenic C57BL/6 mice did not alter the development of EAE. Thus, E- and P-selectin are not required for leukocyte recruitment across the BBB and the development of EAE in C57BL/6 and in SJL mice.

Citing Articles

Targeting Vascular Impairment, Neuroinflammation, and Oxidative Stress Dynamics with Whole-Body Cryotherapy in Multiple Sclerosis Treatment.

Dziedzic A, Maciak K, Miller E, Starosta M, Saluk J Int J Mol Sci. 2024; 25(7).

PMID: 38612668 PMC: 11011409. DOI: 10.3390/ijms25073858.


VE-cadherin in arachnoid and pia mater cells serves as a suitable landmark for in vivo imaging of CNS immune surveillance and inflammation.

Mapunda J, Pareja J, Vladymyrov M, Bouillet E, Helie P, Pleskac P Nat Commun. 2023; 14(1):5837.

PMID: 37730744 PMC: 10511632. DOI: 10.1038/s41467-023-41580-4.


The choroid plexus acts as an immune cell reservoir and brain entry site in experimental autoimmune encephalomyelitis.

Lazarevic I, Soldati S, Mapunda J, Rudolph H, Rosito M, de Oliveira A Fluids Barriers CNS. 2023; 20(1):39.

PMID: 37264368 PMC: 10236715. DOI: 10.1186/s12987-023-00441-4.


The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis.

Angelini G, Bani A, Constantin G, Rossi B Front Cell Neurosci. 2023; 17:1101379.

PMID: 36874213 PMC: 9975172. DOI: 10.3389/fncel.2023.1101379.


Thinking outside the box: non-canonical targets in multiple sclerosis.

Bierhansl L, Hartung H, Aktas O, Ruck T, Roden M, Meuth S Nat Rev Drug Discov. 2022; 21(8):578-600.

PMID: 35668103 PMC: 9169033. DOI: 10.1038/s41573-022-00477-5.